Received Oct 20, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPV | DTAP + IPV (KINRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | y49bz | — |
Administration to a less than 4 year old patient; Inappropriate schedule of vaccine administered; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 6-month-old female patient who received DTPa-IPV (Kinrix) (batch number y49bz) for prophylaxis. On 16-AUG-2024, the patient received Kinrix. On 16-AUG-2024, an unknown time after receiving Kinrix, the patient experienced inappropriate age at vaccine administration (Verbatim: Administration to a less than 4 year old patient) and inappropriate schedule of vaccine administered (Verbatim: Inappropriate schedule of vaccine administered). The outcome of the inappropriate age at vaccine administration and inappropriate schedule of vaccine administered were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 08-OCT-2025 and 09-OCT-2025 The reporter called and reported that the Kinrix, Dtdap and polio, was given to someone under 4, what were the complications of that. The vaccine administration facility was the same as primary reporter. The reporter confirmed Kinrix was the patient 3rd dose of DTaP and IPV. The intention was to administer a DTaP and IPV dose. Call was placed to HCP a day before day of reporting, but MI was unsuccessful in reaching HCP at that time.